Human papillomavirus (HPV) prevalence among men aged 19-27 years in the Netherlands.

Human papillomavirus (HPV) prevalence among men aged 19-27 years in the Netherlands. - HPV prevalence among young men.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON53219

Enrollment

1495

Registered

2023-06-21

Start date

2023-09-26

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HPV human papillomavirus

Interventions

None listed

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - Male - Born from 1996 up to and including 2003 - Provided informed consent

Exclusion criteria

Exclusion criteria: not applicable

Design outcomes

Primary

Measure	Time frame
The primary study outcomes are the prevalence of genital hrHPV overall and types 16 and 18 and the HPV vaccination status after completion of the catch-up campaign.	—

Secondary

Measure	Time frame
Secondary outcomes include the genital prevalences of HPV types other than types 16 and 18 as well as the prevalence of hrHPV in urine to compare the accuracy of hrHPV detection of self-collected first-void urine with self-collected penile swabs.	—

Countries

Netherlands

Outcome results